Skip to main content
. 2016 Oct;44(10):1709–1719. doi: 10.1124/dmd.116.072363

Fig. 6.

Fig. 6.

Inhibition of bupropion metabolism in human liver microsomes by ticlopidine. Ticlopidine IC50 values toward erythrohydrobupropion (A), threohydrobupropion (B), OH-bupropion (C), and 4′-OH-bupropion (D) formation were characterized following a 30-minute preincubation of HLMs with ticlopidine in the presence (filled circles) and absence (filled squares) of NADPH. Significant NADPH-dependent shifts were observed in the IC50 values for each metabolite formation.